AVITA Medical (RCEL) Operating Expenses (2018 - 2025)

AVITA Medical (RCEL) has 8 years of Operating Expenses data on file, last reported at $24.7 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses fell 5.23% year-over-year to $24.7 million; the trailing twelve-month figure through Dec 2025 stood at $101.4 million (down 9.3% YoY), and the FY2025 full-year result was $101.4 million, down 9.31% from the prior year.
• Operating Expenses for Q4 2025 stood at $24.7 million, up from $23.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $30.2 million in Q3 2024 and bottomed at $12.3 million in Q3 2021.
• The 5-year median for Operating Expenses is $22.1 million (2023), against an average of $21.3 million.
• The widest annual swing landed in 2021, when Operating Expenses tumbled 32.95%; it then surged 64.41% in 2023.
• A 5-year view of Operating Expenses shows it stood at $12.3 million in 2021, then climbed by 22.74% to $15.0 million in 2022, then soared by 64.41% to $24.7 million in 2023, then rose by 5.47% to $26.1 million in 2024, then declined by 5.23% to $24.7 million in 2025.
• The last three Operating Expenses figures came in at $24.7 million (Q4 2025), $23.0 million (Q3 2025), and $26.1 million (Q2 2025), per Business Quant data.

Peer Comparison